203 related articles for article (PubMed ID: 25917126)
1. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H
Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126
[TBL] [Abstract][Full Text] [Related]
2. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
4. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.
Hour MJ; Tsai SC; Wu HC; Lin MW; Chung JG; Wu JB; Chiang JH; Tsuzuki M; Yang JS
Int J Oncol; 2012 Oct; 41(4):1513-9. PubMed ID: 22825655
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
Lu Y; Cai Z; Xiao G; Keller ET; Mizokami A; Yao Z; Roodman GD; Zhang J
Cancer Res; 2007 Apr; 67(8):3646-53. PubMed ID: 17440076
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells.
Hwang ES; Park KK
Biosci Biotechnol Biochem; 2010; 74(5):961-7. PubMed ID: 20460721
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
[TBL] [Abstract][Full Text] [Related]
9. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
Lu Y; Cai Z; Galson DL; Xiao G; Liu Y; George DE; Melhem MF; Yao Z; Zhang J
Prostate; 2006 Sep; 66(12):1311-8. PubMed ID: 16705739
[TBL] [Abstract][Full Text] [Related]
12. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.
Yu L; Wang CY; Shi J; Miao L; Du X; Mayer D; Zhang J
Endocrinology; 2011 Mar; 152(3):773-81. PubMed ID: 21248144
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells.
Dagouassat M; Suffee N; Hlawaty H; Haddad O; Charni F; Laguillier C; Vassy R; Martin L; Schischmanoff PO; Gattegno L; Oudar O; Sutton A; Charnaux N
Int J Cancer; 2010 Mar; 126(5):1095-108. PubMed ID: 19642141
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Shi CL; Yu CH; Zhang Y; Zhao D; Chang XH; Wang WH
Asian Pac J Cancer Prev; 2011; 12(2):555-9. PubMed ID: 21545229
[TBL] [Abstract][Full Text] [Related]
15. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
Lu Y; Chen Q; Corey E; Xie W; Fan J; Mizokami A; Zhang J
Clin Exp Metastasis; 2009; 26(2):161-9. PubMed ID: 19002595
[TBL] [Abstract][Full Text] [Related]
16. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
[TBL] [Abstract][Full Text] [Related]
17. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
[TBL] [Abstract][Full Text] [Related]
18. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
19. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop.
Yamamoto T; Eckes B; Mauch C; Hartmann K; Krieg T
J Immunol; 2000 Jun; 164(12):6174-9. PubMed ID: 10843667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]